Pharmaceuticals Market in Germany 2024-2028

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,500	130 Pages	TechNavio	August, 2024	INF19175961

Best Price Guarantee
Price	from $2,500
Length	130 Pages
Publisher	TechNavio
Published Date	August, 2024
SKU	INF19175961

Global Pharmaceuticals Market In Germany 2024-2028

The pharmaceuticals market in germany is forecasted to grow by USD 24.9 bn during 2023-2028, accelerating at a CAGR of 6.79% during the forecast period. The report on the pharmaceuticals market in germany provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by high investment in pharmaceutical industry, increasing geriatric population, and growing number of m and a.

Technavio's pharmaceuticals market in germany is segmented as below:

By Distribution Channel

Pharmacy
Clinic

By Type

Prescription
Non-prescription

By Geographical Landscape

Europe

This study identifies the robust growth of e-commerce as one of the prime reasons driving the pharmaceuticals market in germany growth during the next few years. Also, high demand for personalized medicines and increasing cases of chronic diseases will lead to sizable demand in the market.

The report on the pharmaceuticals market in germany covers the following areas:

Pharmaceuticals market in germany sizing
Pharmaceuticals market in germany forecast
Pharmaceuticals market in germany industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading pharmaceuticals market in germany vendors that include Abbott Laboratories, AbbVie Inc., Amgen Inc., AstraZeneca Plc, Bayer AG, Boehringer Ingelheim International GmbH, Bristol Myers Squibb Co., Eli Lilly and Co., F. Hoffmann La Roche Ltd., Fresenius SE and Co. KGaA, GlaxoSmithKline Plc, Johnson and Johnson Services Inc., MCM Klosterfrau Vertriebsgesellschaft mbH, Merck KGaA, Novartis AG, Novo Nordisk AS, Pfizer Inc., Sanofi SA, STADA Arzneimittel AG, and Teva Pharmaceutical Industries Ltd.. Also, the pharmaceuticals market in germany analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

1 Executive Summary: 1.1 Market overview; Executive Summary - Chart on Market Overview; Executive Summary - Data Table on Market Overview; Executive Summary - Chart on Country Market Characteristics; Executive Summary - Chart on Market Segmentation by Distribution Channel; Executive Summary - Chart on Market Segmentation by Type; Executive Summary - Chart on Company Market Positioning
2 Market Landscape: 2.1 Market ecosystem; Parent Market; Data Table on - Parent Market; 2.2 Market characteristics; Market characteristics analysis; 2.3 Value chain analysis; Value Chain Analysis
3 Market Sizing: 3.1 Market definition; Offerings of companies included in the market definition; 3.2 Market segment analysis; Market segments; 3.3 Market size 2023; 3.4 Market outlook: Forecast for 2023-2028; Chart on Germany - Market size and forecast 2023-2028 ($ billion); Data Table on Germany - Market size and forecast 2023-2028 ($ billion); Chart on Germany: Year-over-year growth 2023-2028 (%); Data Table on Germany: Year-over-year growth 2023-2028 (%)
4 Historic Market Size: 4.1 Pharmaceuticals Market in Germany 2018 - 2022; Historic Market Size - Data Table on Pharmaceuticals Market in Germany 2018 - 2022 ($ billion); 4.2 Distribution Channel segment analysis 2018 - 2022; Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ billion); 4.3 Type segment analysis 2018 - 2022; Historic Market Size - Type Segment 2018 - 2022 ($ billion)
5 Five Forces Analysis: 5.1 Five forces summary; Five forces analysis - Comparison between 2023 and 2028; 5.2 Bargaining power of buyers; Bargaining power of buyers - Impact of key factors 2023 and 2028; 5.3 Bargaining power of suppliers; Bargaining power of suppliers - Impact of key factors in 2023 and 2028; 5.4 Threat of new entrants; Threat of new entrants - Impact of key factors in 2023 and 2028; 5.5 Threat of substitutes; Threat of substitutes - Impact of key factors in 2023 and 2028; 5.6 Threat of rivalry; Threat of rivalry - Impact of key factors in 2023 and 2028; 5.7 Market condition; Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Distribution Channel: 6.1 Market segments; Chart on Distribution Channel - Market share 2023-2028 (%); Data Table on Distribution Channel - Market share 2023-2028 (%); 6.2 Comparison by Distribution Channel; Chart on Comparison by Distribution Channel; Data Table on Comparison by Distribution Channel; 6.3 Pharmacy - Market size and forecast 2023-2028; Chart on Pharmacy - Market size and forecast 2023-2028 ($ billion); Data Table on Pharmacy - Market size and forecast 2023-2028 ($ billion); Chart on Pharmacy - Year-over-year growth 2023-2028 (%); Data Table on Pharmacy - Year-over-year growth 2023-2028 (%); 6.4 Clinic - Market size and forecast 2023-2028; Chart on Clinic - Market size and forecast 2023-2028 ($ billion); Data Table on Clinic - Market size and forecast 2023-2028 ($ billion); Chart on Clinic - Year-over-year growth 2023-2028 (%); Data Table on Clinic - Year-over-year growth 2023-2028 (%); 6.5 Market opportunity by Distribution Channel; Market opportunity by Distribution Channel ($ billion); Data Table on Market opportunity by Distribution Channel ($ billion)
7 Market Segmentation by Type: 7.1 Market segments; Chart on Type - Market share 2023-2028 (%); Data Table on Type - Market share 2023-2028 (%); 7.2 Comparison by Type; Chart on Comparison by Type; Data Table on Comparison by Type; 7.3 Prescription - Market size and forecast 2023-2028; Chart on Prescription - Market size and forecast 2023-2028 ($ billion); Data Table on Prescription - Market size and forecast 2023-2028 ($ billion); Chart on Prescription - Year-over-year growth 2023-2028 (%); Data Table on Prescription - Year-over-year growth 2023-2028 (%); 7.4 Non-prescription - Market size and forecast 2023-2028; Chart on Non-prescription - Market size and forecast 2023-2028 ($ billion); Data Table on Non-prescription - Market size and forecast 2023-2028 ($ billion); Chart on Non-prescription - Year-over-year growth 2023-2028 (%); Data Table on Non-prescription - Year-over-year growth 2023-2028 (%); 7.5 Market opportunity by Type; Market opportunity by Type ($ billion); Data Table on Market opportunity by Type ($ billion)
8 Customer Landscape: 8.1 Customer landscape overview; Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Drivers, Challenges, and Opportunity/Restraints: 9.1 Market drivers; 9.2 Market challenges; 9.3 Impact of drivers and challenges; Impact of drivers and challenges in 2023 and 2028; 9.4 Market opportunities/restraints
10 Competitive Landscape: 10.1 Overview; 10.2 Competitive Landscape; Overview on criticality of inputs and factors of differentiation; 10.3 Landscape disruption; Overview on factors of disruption; 10.4 Industry risks; Impact of key risks on business
11 Competitive Analysis: 11.1 Companies profiled; Companies covered; 11.2 Market positioning of companies; Matrix on companies position and classification; 11.3 Abbott Laboratories; Abbott Laboratories - Overview; Abbott Laboratories - Business segments; Abbott Laboratories - Key news; Abbott Laboratories - Key offerings; Abbott Laboratories - Segment focus; 11.4 AbbVie Inc.; AbbVie Inc. - Overview; AbbVie Inc. - Product / Service; AbbVie Inc. - Key news; AbbVie Inc. - Key offerings; 11.5 AstraZeneca Plc; AstraZeneca Plc - Overview; AstraZeneca Plc - Product / Service; AstraZeneca Plc - Key news; AstraZeneca Plc - Key offerings; 11.6 Bayer AG; Bayer AG - Overview; Bayer AG - Business segments; Bayer AG - Key news; Bayer AG - Key offerings; Bayer AG - Segment focus; 11.7 Boehringer Ingelheim International GmbH; Boehringer Ingelheim International GmbH - Overview; Boehringer Ingelheim International GmbH - Product / Service; Boehringer Ingelheim International GmbH - Key news; Boehringer Ingelheim International GmbH - Key offerings; 11.8 Fresenius SE and Co. KGaA; Fresenius SE and Co. KGaA - Overview; Fresenius SE and Co. KGaA - Business segments; Fresenius SE and Co. KGaA - Key news; Fresenius SE and Co. KGaA - Key offerings; Fresenius SE and Co. KGaA - Segment focus; 11.9 GlaxoSmithKline Plc; GlaxoSmithKline Plc - Overview; GlaxoSmithKline Plc - Business segments; GlaxoSmithKline Plc - Key news; GlaxoSmithKline Plc - Key offerings; GlaxoSmithKline Plc - Segment focus; 11.10 Johnson and Johnson Services Inc.; Johnson and Johnson Services Inc. - Overview; Johnson and Johnson Services Inc. - Business segments; Johnson and Johnson Services Inc. - Key news; Johnson and Johnson Services Inc. - Key offerings; Johnson and Johnson Services Inc. - Segment focus; 11.11 MCM Klosterfrau Vertriebsgesellschaft mbH; MCM Klosterfrau Vertriebsgesellschaft mbH - Overview; MCM Klosterfrau Vertriebsgesellschaft mbH - Product / Service; MCM Klosterfrau Vertriebsgesellschaft mbH - Key offerings; 11.12 Merck KGaA; Merck KGaA - Overview; Merck KGaA - Business segments; Merck KGaA - Key news; Merck KGaA - Key offerings; Merck KGaA - Segment focus; 11.13 Novartis AG; Novartis AG - Overview; Novartis AG - Business segments; Novartis AG - Key news; Novartis AG - Key offerings; Novartis AG - Segment focus; 11.14 Pfizer Inc.; Pfizer Inc. - Overview; Pfizer Inc. - Product / Service; Pfizer Inc. - Key news; Pfizer Inc. - Key offerings; 11.15 Sanofi SA; Sanofi SA - Overview; Sanofi SA - Business segments; Sanofi SA - Key news; Sanofi SA - Key offerings; Sanofi SA - Segment focus; 11.16 STADA Arzneimittel AG; STADA Arzneimittel AG - Overview; STADA Arzneimittel AG - Business segments; STADA Arzneimittel AG - Key offerings; STADA Arzneimittel AG - Segment focus; 11.17 Teva Pharmaceutical Industries Ltd.; Teva Pharmaceutical Industries Ltd. - Overview; Teva Pharmaceutical Industries Ltd. - Business segments; Teva Pharmaceutical Industries Ltd. - Key news; Teva Pharmaceutical Industries Ltd. - Key offerings; Teva Pharmaceutical Industries Ltd. - Segment focus
12 Appendix: 12.1 Scope of the report; 12.2 Inclusions and exclusions checklist; Inclusions checklist; Exclusions checklist; 12.3 Currency conversion rates for US$; Currency conversion rates for US$; 12.4 Research methodology; Research methodology; 12.5 Data procurement; Information sources; 12.6 Data validation; Data validation; 12.7 Validation techniques employed for market sizing; Validation techniques employed for market sizing; 12.8 Data synthesis; Data synthesis; 12.9 360 degree market analysis; 360 degree market analysis; 12.10 List of abbreviations; List of abbreviations
Exhibits:: Exhibits1: Executive Summary - Chart on Market Overview; Exhibits2: Executive Summary - Data Table on Market Overview; Exhibits3: Executive Summary - Chart on Country Market Characteristics; Exhibits4: Executive Summary - Chart on Market Segmentation by Distribution Channel; Exhibits5: Executive Summary - Chart on Market Segmentation by Type; Exhibits6: Executive Summary - Chart on Company Market Positioning; Exhibits7: Parent Market; Exhibits8: Data Table on - Parent Market; Exhibits9: Market characteristics analysis; Exhibits10: Value Chain Analysis; Exhibits11: Offerings of companies included in the market definition; Exhibits12: Market segments; Exhibits13: Chart on Germany - Market size and forecast 2023-2028 ($ billion); Exhibits14: Data Table on Germany - Market size and forecast 2023-2028 ($ billion); Exhibits15: Chart on Germany: Year-over-year growth 2023-2028 (%); Exhibits16: Data Table on Germany: Year-over-year growth 2023-2028 (%); Exhibits17: Historic Market Size - Data Table on Pharmaceuticals Market in Germany 2018 - 2022 ($ billion); Exhibits18: Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ billion); Exhibits19: Historic Market Size - Type Segment 2018 - 2022 ($ billion); Exhibits20: Five forces analysis - Comparison between 2023 and 2028; Exhibits21: Bargaining power of buyers - Impact of key factors 2023 and 2028; Exhibits22: Bargaining power of suppliers - Impact of key factors in 2023 and 2028; Exhibits23: Threat of new entrants - Impact of key factors in 2023 and 2028; Exhibits24: Threat of substitutes - Impact of key factors in 2023 and 2028; Exhibits25: Threat of rivalry - Impact of key factors in 2023 and 2028; Exhibits26: Chart on Market condition - Five forces 2023 and 2028; Exhibits27: Chart on Distribution Channel - Market share 2023-2028 (%); Exhibits28: Data Table on Distribution Channel - Market share 2023-2028 (%); Exhibits29: Chart on Comparison by Distribution Channel; Exhibits30: Data Table on Comparison by Distribution Channel; Exhibits31: Chart on Pharmacy - Market size and forecast 2023-2028 ($ billion); Exhibits32: Data Table on Pharmacy - Market size and forecast 2023-2028 ($ billion); Exhibits33: Chart on Pharmacy - Year-over-year growth 2023-2028 (%); Exhibits34: Data Table on Pharmacy - Year-over-year growth 2023-2028 (%); Exhibits35: Chart on Clinic - Market size and forecast 2023-2028 ($ billion); Exhibits36: Data Table on Clinic - Market size and forecast 2023-2028 ($ billion); Exhibits37: Chart on Clinic - Year-over-year growth 2023-2028 (%); Exhibits38: Data Table on Clinic - Year-over-year growth 2023-2028 (%); Exhibits39: Market opportunity by Distribution Channel ($ billion); Exhibits40: Data Table on Market opportunity by Distribution Channel ($ billion); Exhibits41: Chart on Type - Market share 2023-2028 (%); Exhibits42: Data Table on Type - Market share 2023-2028 (%); Exhibits43: Chart on Comparison by Type; Exhibits44: Data Table on Comparison by Type; Exhibits45: Chart on Prescription - Market size and forecast 2023-2028 ($ billion); Exhibits46: Data Table on Prescription - Market size and forecast 2023-2028 ($ billion); Exhibits47: Chart on Prescription - Year-over-year growth 2023-2028 (%); Exhibits48: Data Table on Prescription - Year-over-year growth 2023-2028 (%); Exhibits49: Chart on Non-prescription - Market size and forecast 2023-2028 ($ billion); Exhibits50: Data Table on Non-prescription - Market size and forecast 2023-2028 ($ billion); Exhibits51: Chart on Non-prescription - Year-over-year growth 2023-2028 (%); Exhibits52: Data Table on Non-prescription - Year-over-year growth 2023-2028 (%); Exhibits53: Market opportunity by Type ($ billion); Exhibits54: Data Table on Market opportunity by Type ($ billion); Exhibits55: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Exhibits56: Impact of drivers and challenges in 2023 and 2028; Exhibits57: Overview on criticality of inputs and factors of differentiation; Exhibits58: Overview on factors of disruption; Exhibits59: Impact of key risks on business; Exhibits60: Companies covered; Exhibits61: Matrix on companies position and classification; Exhibits62: Abbott Laboratories - Overview; Exhibits63: Abbott Laboratories - Business segments; Exhibits64: Abbott Laboratories - Key news; Exhibits65: Abbott Laboratories - Key offerings; Exhibits66: Abbott Laboratories - Segment focus; Exhibits67: AbbVie Inc. - Overview; Exhibits68: AbbVie Inc. - Product / Service; Exhibits69: AbbVie Inc. - Key news; Exhibits70: AbbVie Inc. - Key offerings; Exhibits71: AstraZeneca Plc - Overview; Exhibits72: AstraZeneca Plc - Product / Service; Exhibits73: AstraZeneca Plc - Key news; Exhibits74: AstraZeneca Plc - Key offerings; Exhibits75: Bayer AG - Overview; Exhibits76: Bayer AG - Business segments; Exhibits77: Bayer AG - Key news; Exhibits78: Bayer AG - Key offerings; Exhibits79: Bayer AG - Segment focus; Exhibits80: Boehringer Ingelheim International GmbH - Overview; Exhibits81: Boehringer Ingelheim International GmbH - Product / Service; Exhibits82: Boehringer Ingelheim International GmbH - Key news; Exhibits83: Boehringer Ingelheim International GmbH - Key offerings; Exhibits84: Fresenius SE and Co. KGaA - Overview; Exhibits85: Fresenius SE and Co. KGaA - Business segments; Exhibits86: Fresenius SE and Co. KGaA - Key news; Exhibits87: Fresenius SE and Co. KGaA - Key offerings; Exhibits88: Fresenius SE and Co. KGaA - Segment focus; Exhibits89: GlaxoSmithKline Plc - Overview; Exhibits90: GlaxoSmithKline Plc - Business segments; Exhibits91: GlaxoSmithKline Plc - Key news; Exhibits92: GlaxoSmithKline Plc - Key offerings; Exhibits93: GlaxoSmithKline Plc - Segment focus; Exhibits94: Johnson and Johnson Services Inc. - Overview; Exhibits95: Johnson and Johnson Services Inc. - Business segments; Exhibits96: Johnson and Johnson Services Inc. - Key news; Exhibits97: Johnson and Johnson Services Inc. - Key offerings; Exhibits98: Johnson and Johnson Services Inc. - Segment focus; Exhibits99: MCM Klosterfrau Vertriebsgesellschaft mbH - Overview; Exhibits100: MCM Klosterfrau Vertriebsgesellschaft mbH - Product / Service; Exhibits101: MCM Klosterfrau Vertriebsgesellschaft mbH - Key offerings; Exhibits102: Merck KGaA - Overview; Exhibits103: Merck KGaA - Business segments; Exhibits104: Merck KGaA - Key news; Exhibits105: Merck KGaA - Key offerings; Exhibits106: Merck KGaA - Segment focus; Exhibits107: Novartis AG - Overview; Exhibits108: Novartis AG - Business segments; Exhibits109: Novartis AG - Key news; Exhibits110: Novartis AG - Key offerings; Exhibits111: Novartis AG - Segment focus; Exhibits112: Pfizer Inc. - Overview; Exhibits113: Pfizer Inc. - Product / Service; Exhibits114: Pfizer Inc. - Key news; Exhibits115: Pfizer Inc. - Key offerings; Exhibits116: Sanofi SA - Overview; Exhibits117: Sanofi SA - Business segments; Exhibits118: Sanofi SA - Key news; Exhibits119: Sanofi SA - Key offerings; Exhibits120: Sanofi SA - Segment focus; Exhibits121: STADA Arzneimittel AG - Overview; Exhibits122: STADA Arzneimittel AG - Business segments; Exhibits123: STADA Arzneimittel AG - Key offerings; Exhibits124: STADA Arzneimittel AG - Segment focus; Exhibits125: Teva Pharmaceutical Industries Ltd. - Overview; Exhibits126: Teva Pharmaceutical Industries Ltd. - Business segments; Exhibits127: Teva Pharmaceutical Industries Ltd. - Key news; Exhibits128: Teva Pharmaceutical Industries Ltd. - Key offerings; Exhibits129: Teva Pharmaceutical Industries Ltd. - Segment focus; Exhibits130: Inclusions checklist; Exhibits131: Exclusions checklist; Exhibits132: Currency conversion rates for US$; Exhibits133: Research methodology; Exhibits134: Information sources; Exhibits135: Data validation; Exhibits136: Validation techniques employed for market sizing; Exhibits137: Data synthesis; Exhibits138: 360 degree market analysis; Exhibits139: List of abbreviations